QCBGX
Price
$20.58
Change
+$0.04 (+0.19%)
Updated
Mar 31 closing price
Net Assets
254.83M
RLBBX
Price
$33.86
Change
+$0.12 (+0.36%)
Updated
Mar 31 closing price
Net Assets
232.71B
Ad is loading...

QCBGX vs RLBBX

Header iconQCBGX vs RLBBX Comparison
Open Charts QCBGX vs RLBBXBanner chart's image
Federated Hermes MDT Balanced C
Price$20.58
Change+$0.04 (+0.19%)
VolumeN/A
Net Assets254.83M
American Funds American Balanced R2
Price$33.86
Change+$0.12 (+0.36%)
VolumeN/A
Net Assets232.71B
QCBGX vs RLBBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QCBGX vs. RLBBX commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCBGX is a Buy and RLBBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 233B vs. QCBGX (255M). RLBBX pays higher dividends than QCBGX: RLBBX (1.25) vs QCBGX (0.65). QCBGX was incepted earlier than RLBBX: QCBGX (20 years) vs RLBBX (23 years). QCBGX (2.12) is less costly to investors than RLBBX (1.33). RLBBX is a more actively managed with annual turnover of: 171.00 vs. QCBGX (68.00). RLBBX has a lower initial minimum investment than QCBGX: RLBBX (250) vs QCBGX (1500). RLBBX annual gain was more profitable for investors over the last year : 2.08 vs. QCBGX (-2.14). RLBBX return over 5 years is better than : 45.44 vs. QCBGX (36.40).
QCBGXRLBBXQCBGX / RLBBX
Total Expense Ratio2.121.33159%
Annual Report Gross Expense Ratio2.121.33159%
Fund Existence20 years23 years-
Gain YTD-0.628-0.432145%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets255M233B0%
Annual Yield % from dividends0.651.2552%
Returns for 1 year-2.142.08-103%
Returns for 3 years1.219.7012%
Returns for 5 years36.4045.4480%
Returns for 10 years28.1645.2562%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NLSP1.540.24
+18.46%
Nls Pharmaceutics Ltd
IART21.990.30
+1.38%
Integra LifeSciences Holdings Corp
SFWL0.98N/A
+0.18%
Shengfeng Development Limited
BMRN70.69-0.75
-1.05%
BioMarin Pharmaceutical
VMEO5.26-0.06
-1.13%
Vimeo